Chemokine analogs granted US patent (PharmaBiz)

Chemokine analogs granted US patent (PharmaBiz)
Chemokine Therapeutics Corp., a biotechnology company, announced that the US Patent and Trademark Office has issued US Patent 7,091,310 B2 relating to chemokine analogs for the treatment of human disease.